Cholestyramine Completed Phase 1 Trials for Orphan Cholestatic Liver Diseases / Primary Biliary Cholangitis / Progressive Familial Intrahepatic Cholestasis (PFIC) / Alagille Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02963077A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384